Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Trade this ETF at your broker
Index | Harbor Health Care |
Investment focus | Equity, World, Health Care |
Fund size | EUR 15 m |
Total expense ratio | 0.89% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 22.99% |
Inception/ Listing Date | 4 April 2019 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | HANetf |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | J.P. Morgan Administration Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | J.P. Morgan SE - Dublin Branch |
Revision Company | Ernst and Young |
Fiscal Year End | 31 March |
Swiss representative | Waystone |
Swiss paying agent | Helvetische Bank |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Eli Lilly & Co. | 9.18% |
Ascendis Pharma A/S | 9.01% |
Legend Biotech | 8.91% |
UnitedHealth Group | 7.19% |
Masimo Corp. | 5.06% |
Vaxcyte | 4.75% |
Rhythm Pharmaceuticals | 4.26% |
DexCom | 3.94% |
Genedx Holdings | 3.67% |
Natera | 3.52% |
United States | 69.88% |
Ireland | 3.21% |
Netherlands | 2.53% |
Switzerland | 2.36% |
Other | 22.02% |
Health Care | 77.99% |
Other | 22.03% |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 1.50€ 1.50% | 0.00€ | View offer* |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
![]() | 0.99€ | 2736 | View offer* | |
![]() | 0.00€ | 1457 | View offer* | |
![]() | 1.00€ | 2407 | View offer* | |
![]() | 0.00€ | 1637 | View offer* | |
![]() | 0.00€ | 1687 | View offer* |
YTD | -5.47% |
1 month | +0.00% |
3 months | +8.62% |
6 months | -7.35% |
1 year | -8.75% |
3 years | -15.27% |
5 years | -28.40% |
Since inception (MAX) | -12.70% |
2024 | -3.47% |
2023 | -1.92% |
2022 | -25.63% |
2021 | +1.00% |
Volatility 1 year | 22.99% |
Volatility 3 years | 21.89% |
Volatility 5 years | 22.69% |
Return per risk 1 year | -0.38 |
Return per risk 3 years | -0.25 |
Return per risk 5 years | -0.28 |
Maximum drawdown 1 year | -21.98% |
Maximum drawdown 3 years | -33.05% |
Maximum drawdown 5 years | -46.61% |
Maximum drawdown since inception | -46.61% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | W311 | - - | - - | - |
Borsa Italiana | EUR | WELL | WELL IM WELLEUIV | WELL.MI WELLEURINAV=SOLA | RBC Europe Ltd |
Euronext Paris | EUR | WELL | WELL FP WELLEUIV | WELP.PA WELLEURINAV=SOLA | RBC Europe Ltd |
London Stock Exchange | GBX | WELP | RBC Europe Ltd | ||
London Stock Exchange | USD | WELL | WELL LN | HAWELL.L | RBC Europe Ltd |
London Stock Exchange | GBP | - | WELP LN | WELP.L | RBC Europe Ltd |
SIX Swiss Exchange | CHF | WELL | WELL SW WELLEUIV | WELL.S WELLEURINAV=SOLA | RBC Europe Ltd |
XETRA | EUR | W311 | W311 GY WELLEUIV | W311.DE WELLEURINAV=SOLA | RBC Europe Ltd |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 796 | 0.40% p.a. | Accumulating | Sampling |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 72 | 0.49% p.a. | Accumulating | Full replication |
L&G Pharma Breakthrough UCITS ETF | 14 | 0.49% p.a. | Accumulating | Full replication |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 1C | 5 | 0.30% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 5 | 0.35% p.a. | Accumulating | Full replication |